Chong Kun Dang Pharmaceutical Corp. is a Korea-based company mainly engaged in the production and sale of pharmaceuticals. The Company is involved of the manufacturing and sale of prescription drugs, over the counter (OTC) drugs, health supplements, and quasi-drugs. The main products include diabetes drugs, antiviral drugs, hypertension treatments, and hyperlipemia therapies. In addition, the Company is engaged in the production and sale of medical devices, diagnostic reagents, muscle relaxants under the name of Botulax, as well as cosmetics such as mederma gels. Diagnostic reagents include helicobacter pylori urease detection reagents under the name of Hp kit. The Company distributes its products within the domestic market and to overseas markets, including Japan, Vietnam and China.